Amphastar Pharmaceuticals Inc

AMPH's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

AMPH Growth rates comparisons

Looking into Amphastar Pharmaceuticals Inc growth rates, revenue grew by 11.69 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1512

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.73 %

Amphastar Pharmaceuticals Inc 's net income grew by 71.62 % in IV. Quarter 2022 year on year, above company average,

• More on AMPH's Growth

AMPH's Valuation comparisons

Amphastar Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Amphastar Pharmaceuticals Inc PEG ratio is at 0.57 Company is currently trading with Price to Cash flow multiple of 66.9 in trailing twelve-month period.

Company

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 3.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.59.

• More on AMPH's Valuation

Total Debt (Millions $)	76
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	6.24
Tangible Book Value (Per Share $)	9.36

AMPH's Valuation comparisons

Company

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 3.99.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.59.

Amphastar Pharmaceuticals Inc Price to Book Ratio is at 3.76 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on AMPH's Valuation

• Market Capitalization (Millions $)	1,990
• Shares Outstanding (Millions)	53
• Employees	-
• Revenues (TTM) (Millions $)	499
• Net Income (TTM) (Millions $)	91
• Cash Flow (TTM) (Millions $)	30
• Capital Exp. (TTM) (Millions $)	-24
• Total Debt (Millions $)	76
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	6.24
• Tangible Book Value (Per Share $)	9.36

• Market Capitalization (Millions $)	1,990
• Shares Outstanding (Millions)	53
• Employees	-
• Revenues (TTM) (Millions $)	499
• Net Income (TTM) (Millions $)	91
• Cash Flow (TTM) (Millions $)	30
• Capital Exp. (TTM) (Millions $)	-24

AMPH's Profitability Comparisons
Amphastar Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 28.02 % from 19.34 % in III. Quarter. Amphastar Pharmaceuticals Inc net profit margin of 25.12 % is currently ranking no. 28 in Major Pharmaceutical Preparations industry, ranking no. 52 in Healthcare sector and number 643 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	3.99
• Total Debt to Equity (MRQ)	0.14
• Tangible Leverage Ratio (MRQ)	0.43
• Asset Turnover Ratio (TTM)	0.69
• Inventory Turnover Ratio (TTM)	2.5

AMPH's Profitability Comparisons

Amphastar Pharmaceuticals Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2022 to 28.02 % from 19.34 % in III. Quarter.

Amphastar Pharmaceuticals Inc net profit margin of 25.12 % is currently ranking no. 28 in Major Pharmaceutical Preparations industry, ranking no. 52 in Healthcare sector and number 643 in S&P 500.

• More on AMPH's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar AXTI's Profile Stock Price AXTI's Financials Business Description Fundamentals Charts & Quotes AXTI's News Suppliers AXTI's Competitors Customers & Markets Economic Indicators AXTI's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071